Marcaine Adrenaline (Bupivacaine Hydrochloride, Epinephrine)

Bupivacaine blocks voltage‑gated sodium channels on nerve membranes, preventing the influx of sodium ions that is required for depolarisation. This inhibition stops the propagation of nerve impulses, resulting in loss of sensation in the targeted area. The addition of epinephrine causes local vasoconstriction, slowing systemic absorption and prolonging the anesthetic effect.

The dose of Marcaine Adrenaline is determined by the prescribing clinician based on the specific procedure, patient characteristics, and clinical judgement. No standard dosing regimen is provided here; the prescriber will calculate the appropriate volume and concentration required for safe and effective anesthesia.

Safety data for Marcaine Adrenaline in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Clinicians should weigh potential benefits against risks and consider alternative options when treating pregnant or nursing patients.

To order Marcaine Adrenaline, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.

The most common alternative to Marcaine Adrenaline is lidocaine, a shorter‑acting local anesthetic without a vasoconstrictor. Bupivacaine provides a longer duration of action, which can be advantageous for prolonged procedures, while epinephrine in Marcaine Adrenaline further extends this effect and reduces bleeding. However, bupivacaine carries a higher risk of cardiotoxicity if inadvertently injected intravascularly, requiring careful technique.

Marcaine Adrenaline should be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before use, inspect the container for any particulate matter or discoloration and discard if the integrity is compromised.

Marcaine Adrenaline is administered by injection. For epidural anesthesia, the solution is injected into the epidural space under sterile technique. For infiltration, it is injected directly into the tissue surrounding the surgical site. For intra‑articular use, the drug is injected into the joint cavity. Aspiration before injection helps avoid inadvertent intravascular administration.

Serious risks include cardiac arrhythmias, severe hypotension or hypertension, seizures, and methemoglobinemia. These events are rare but can be life‑threatening, especially if the drug enters the bloodstream in large amounts. Immediate monitoring of cardiovascular and neurological status is essential during and after administration.

Marcaine Adrenaline should be avoided in patients with known hypersensitivity to bupivacaine, epinephrine, or other amide‑type local anesthetics. It is also contraindicated in individuals with severe cardiac conduction disorders, uncontrolled hypertension, or those taking monoamine oxidase inhibitors without appropriate medical supervision.